FDA Inspection 996015 — Central California Blood Center
The FDA completed an inspection of Central California Blood Center on Dec 21, 2016 in Fresno, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 21, 2016
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Fresno, CA (United States)